UniSa - IRIS Institutional Research Information System

RAIMONDO, ANNUNZIATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.408
NA - Nord America 1.057
AS - Asia 992
SA - Sud America 146
AF - Africa 16
OC - Oceania 2
Totale 3.621
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.036
IT - Italia 922
HK - Hong Kong 419
SG - Singapore 287
RU - Federazione Russa 144
BR - Brasile 136
CN - Cina 124
DE - Germania 74
IE - Irlanda 60
IN - India 46
NL - Olanda 43
SE - Svezia 33
KR - Corea 32
FI - Finlandia 23
GB - Regno Unito 22
VN - Vietnam 21
FR - Francia 15
AT - Austria 14
TR - Turchia 14
JP - Giappone 13
UA - Ucraina 12
CA - Canada 11
CH - Svizzera 11
PL - Polonia 8
ES - Italia 7
MX - Messico 6
IQ - Iraq 5
PH - Filippine 5
PK - Pakistan 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
SA - Arabia Saudita 4
AR - Argentina 3
CZ - Repubblica Ceca 3
IR - Iran 3
PT - Portogallo 3
AU - Australia 2
BD - Bangladesh 2
BE - Belgio 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
HR - Croazia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
LT - Lituania 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
RO - Romania 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.621
Salva come PNG Salva come JPEG
Città #
Hong Kong 415
Chandler 231
Princeton 149
Rome 100
Singapore 100
Milan 79
Moscow 60
Dublin 58
Ann Arbor 52
Naples 52
Munich 43
Ashburn 39
Salerno 36
Wilmington 34
Dallas 28
Beijing 27
Amsterdam 22
Los Angeles 20
Seattle 20
Andover 17
Houston 16
Palermo 15
Dong Ket 14
Jacksonville 14
São Paulo 14
Bari 13
Bologna 13
Columbus 13
Turin 13
Genoa 12
London 12
The Dalles 12
Tokyo 12
Turku 12
Woodbridge 12
Mumbai 11
Nuremberg 11
Cava de' Tirreni 10
Fisciano 10
Verona 10
Boardman 9
Chennai 9
Florence 9
New York 9
Pune 9
Albignasego 8
Brooklyn 8
Padova 8
West Jordan 8
Boston 7
Guangzhou 7
Santa Clara 7
Sarno 7
Stockholm 7
Catania 6
Council Bluffs 6
Helsinki 6
Lamezia Terme 6
Napoli 6
Warsaw 6
Acerra 5
Asti 5
Atlanta 5
Domicella 5
Istanbul 5
Izmir 5
Lappeenranta 5
Marcianise 5
Montreal 5
Nanjing 5
Ottaviano 5
Phoenix 5
Redwood City 5
Shanghai 5
Venice 5
Aversa 4
Barcelona 4
Belo Horizonte 4
Bernezzo 4
Cerignola 4
Cinisello Balsamo 4
Heilbronn 4
Lucca 4
Marseille 4
Messina 4
Modena 4
Norwalk 4
Paris 4
Rimini 4
San Francisco 4
Taranto 4
Vienna 4
Bengaluru 3
Brasília 3
Cape Town 3
Cebu City 3
Charlotte 3
Chicago 3
Clifton 3
Contagem 3
Totale 2.146
Salva come PNG Salva come JPEG
Nome #
Eruzione cutanea dopo vaccino SARS CoV-2 in paziente psoriasico trattato con MTX 570
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 166
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study 146
Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews 95
Understanding the role of haptoglobin in psoriasis: Effects of ultraviolet B 92
058 Oxidative stress in atopic dermatitis and cardiovascular disease: urinary biopyrrins as possible biomarker 91
Psoriasis and bone damage: the role of phosphodiesterase 4 in the pro-osteoclastogenic process induced by skin inflammation. 83
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 77
An acute spondyloarthritis during successful treatment with dupilumab for severe atopic dermatitis 72
Sicurezza ed efficacia di Apremilast in paziente psoriasico oncologico in terapia con pembrolizumab 71
Interleukin-33: increasing role in dermatological conditions 64
Psoriasi e salute del cavo orale: un nesso da non sottovalutare. I primi risultati di uno studio clinico osservazionale 61
Secukinumab e popolazioni speciali: focus su tubercolosi latente ed epatite virale: studio retrospettivo 60
Anti-tumor necrosis factor-α therapy in the management of psoriasis and B-chronic lymphocytic leukemia 56
Atopic dermatitis: Epidemiology and clinical phenotypes 53
Apremilast, NB-UVB e MTX: confronto del profilo di efficacia, di sicurezza e capacità di modulazione dell’infiammazione sistemica nei pazienti psoriasici. Studio osservazionale di coorte prospettico 49
European Task Force on Contact Dermatitis statement on coronavirus disease-19 (COVID-19) outbreak and the risk of adverse cutaneous reactions 48
IL-33 is regulated by TNF-α in normal and psoriatic skin 47
Anti-IL-17 therapy rapidly decreases osteoclast activity in psoriatic patients: A novel quality in addition to its efficacy and safety 46
121 Oxidative stress in atopic dermatitis: urinary biopyrrins as possible new biomarker 46
A preterm infant with benign neonatal hemangiomatosis and persistent patent ductus arteriosus: A curious comorbidity 44
Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris 42
Hair whitening in a patient with psoriasis during failure of adalimumab treatment reversed by ixekizumab 42
Confronto del profilo di efficacia, sicurezza e compliance tra Apremilast, NB-UVB e MTX nei pazienti psoriasici: i primi risultati di uno studio osservazionale multicentrico italiano 41
A journey into psoriasis: From the adipose tissue to the skin 41
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 40
IL-26 in allergic contact dermatitis: Resource in a state of readiness 40
"Pro-osteoclastogenesis march" is induced by cutaneous pro-inflammatory mediators 40
Carcinoma basocellulare con invasione perineurale: gestione terapeutica 39
Guselkumab for the treatment of psoriasis 39
Human Microbiome: Composition and Role in Inflammatory Skin Diseases 38
Clinical predictors of psoriatic arthritis and osteoclast differentiation 38
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 37
The important role of interdisciplinary collaboration in the management of a melanocytic skin lesion 37
The laboratory role in the assessment of sensitization and irritation potential of cosmetics 37
Immuno-Pathogenesis of Chronic Inflammatory Skin Diseases: Novel Molecular Targets and Biomarkers 36
From the skin to the bone: Pro-osteoclastogenesis inflammatory march 36
A potential prognostic test for bone erosion development in patients with cutaneous predictive sites for psoriatic arthritis 36
Flash-pumped pulsed dye laser for vascular skin lesions: our experience and an overview of the literature 35
Paraoxonases and psoriasis: negative imbalance of anti--oxidant endogenous mechanisms 34
Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review 33
Cutaneous Eruption after SARS-CoV-2 vaccine in psoriatic patient treated with methotrexate 32
RAST: Clinical applications 32
UVB-induced p53 is reduced by a mixture of natural extracts 32
Photosensitivity and cancer immune-targeted therapies 31
IL-26: A new actor in allergic contact dermatitis 31
The effects of skin psoriasis inflammation on adipose tissue-derived mediators and viceversa 31
Presence of BAG3 protein in serum samples from patients affected by psoriasis 29
Psoriasis, cardiovascular events, and biologics: Lights and shadows 29
Pro-osteoclastogenesis march is enhanced by cutaneous pro-inflammatory mediators 29
Disseminated mucocutaneous Candida infection during anti IL-17A therapy in a psoriatic patient 27
Oral Lesions and Oral Health-Related Quality of Life in Adult Patients with Psoriasis: A Retrospective Chart Review 26
Misurazione dinamica degli inquinanti in pazienti affetti da dermatite atopica 26
Farmaci biologici e small molecules in dermatite atopica: confronto su efficacia e sugli effetti nella gestione del prurito 26
The role of the dermatologist in the immune-mediated/allergic diseases – position statement of the EADV task force on contact dermatitis, EADV task force on occupational skin diseases, UEMS-EBDV subcommission allergology and European Dermatology Forum 26
Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection 26
A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination 24
Polymorphic light eruption: What's new in pathogenesis and management 24
New insights into mechanism of Notch signaling in hidradenitis suppurativa 24
Guselkumab e psoriasi in sedi difficili: efficacia ed impatto sulla qualità di vita in pazienti naive o bio experienced 23
Psoriasi eritrodermica: rapida efficacia di bimekizumab 23
Psoriasiform dermatitis during dupilumab treatment in atopic patient resolved after combo-therapy with methotrexate 21
Psoriasi e terapia con guselkumab: panoramica 2022 dal centro prescrittore AOU Salerno 21
Limitations of current monoclonal antibodies for plaque-type psoriasis and an outlook for the future 21
Systemic inflammation: psoriasis as a model…in Naples 21
Ultrasonography in the management of a recurrent and eruptive lobular capillary hemangioma and resolution with intense pulsed light 20
Novel interactions among ultraviolet B, skin and adipose tissue 20
Notch dysregulation and hidradenitis suppurativa, psoriasis, atopic dermatitis and lichen planus: let's talk about Numb 19
Letters to the editor 19
Photodermatoses and Skin Cancer 19
Dupilumab therapy reduces urinary biopyrrin levels in atopic patients: a new possible biomarker of oxidative status in atopic dermatitis 18
Studio osservazionale descrittivo per la valutazione della prevalenza della psoriasi nei pazienti adulti dislipidemici in terapia monoclonale con anti-PCSK9 18
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study 17
Dermatite atopica e stress ossidativo: nuovi biomarker 17
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis 17
Sociodemographic, clinical and therapeutic factors as predictors of life quality impairment in psoriasis: A cross-sectional study in Italy 16
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients 15
Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study 13
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real‐world study 12
Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy 12
PDE4 Inhibition Reduced Osteoclast Differentiation in Psoriatic Patients 10
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study 10
Oral Diseases During Systemic Psoriatic Drugs: A Review of the Literature and Case Series 9
Oxidative Stress in Atopic Dermatitis and Possible Biomarkers: Present and Future 9
Totale 3.723
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.149
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 3 0 11 7 19 0 1 10 8 16
2021/2022255 2 4 3 20 30 2 0 11 21 5 40 117
2022/2023544 55 56 27 74 27 102 6 53 87 15 27 15
2023/2024541 23 54 39 26 35 45 28 46 18 66 54 107
2024/20251.533 65 36 115 137 79 187 169 86 240 88 145 186
2025/2026656 252 404 0 0 0 0 0 0 0 0 0 0
Totale 3.723